[EPS Miss by 33%] Protalix BioTherapeutics - 2024 Q3 Earnings Analysis

[EPS Miss by 4%] Iterum Therapeutics - 2024 Q3 Earnings AnalysisПодробнее

PDS Biotech - 2024 Q3 Earnings AnalysisПодробнее

[EPS Miss by 59%] Invivyd - 2024 Q3 Earnings AnalysisПодробнее

[EPS Miss by 44%] Local Bounti - 2024 Q3 Earnings AnalysisПодробнее

[EPS Miss by 12%] Capricor Therapeutics - 2024 Q3 Earnings AnalysisПодробнее

[EPS Beat by 31%] Bio-Path Holdings - 2024 Q3 Earnings AnalysisПодробнее

[EPS Miss by 3%] Best Buy - 2024 Q3 Earnings AnalysisПодробнее

[EPS Beat by 5%] SpringWorks Therapeutics - 2024 Q3 Earnings AnalysisПодробнее

[EPS Miss by 9%] Cellectar Biosciences - 2024 Q3 Earnings AnalysisПодробнее

[EPS Miss by 11%] Akoya Biosciences - 2024 Q3 Earnings AnalysisПодробнее

[EPS Beat by 11%] Integral Ad Science - 2024 Q3 Earnings AnalysisПодробнее

[EPS Miss by 25%] Taysha Gene Therapies - 2024 Q3 Earnings AnalysisПодробнее

[EPS Miss by 11%] ARS Pharmaceuticals - 2024 Q3 Earnings AnalysisПодробнее

[EPS Miss by 10%] Scholar Rock - 2024 Q3 Earnings AnalysisПодробнее

[EPS Miss by 92%] Advance Auto Parts - 2024 Q3 Earnings AnalysisПодробнее

[EPS Beat by 38%] MiNK Therapeutics - 2024 Q3 Earnings AnalysisПодробнее

[EPS Miss by 19%] Target - 2024 Q3 Earnings AnalysisПодробнее

[EPS Beat by 8%] Daré Bioscience - 2024 Q3 Earnings AnalysisПодробнее